申请人:NUVATION BIO INC.
公开号:US10807994B2
公开(公告)日:2020-10-20
Heterocyclic compounds of Formula (I):
as Wee1 inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
式 (I) 的杂环化合物:
提供了作为 Wee1 抑制剂的杂环化合物。这些化合物可用作治疗疾病的药物,尤其可用于肿瘤学。